Exodus Point Capital Management, LP Immuno Gen, Inc. Transaction History

Exodus Point Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$14.09 - $19.87 $545,747 - $769,624	38,733 New	38,733 $615,000
Q1 2023 May 11, 2023	BUY	$3.67 - $4.92 $114,753 - $153,838	31,268 New	31,268 $120,000
Q3 2022 Nov 10, 2022	BUY	$4.48 - $6.47 $937,578 - $1.35 Million	209,281 Added 138.2%	360,717 $1.72 Million
Q2 2022 Aug 19, 2022	BUY	$3.15 - $5.76 $2,302 - $4,210	731 Added 0.49%	151,436 $681,000
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $461,903 - $811,041	108,428 Added 256.47%	150,705 $717,000
Q4 2021 Feb 11, 2022	SELL	$4.75 - $7.5 $1.21 Million - $1.9 Million	-253,725 Reduced 85.72%	42,277 $314,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $901,270 - $1.18 Million	179,536 Added 154.15%	296,002 $1.68 Million
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $117,687 - $174,803	20,326 Added 21.14%	116,466 $768,000
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $493,610 - $799,648	75,940 Added 375.94%	96,140 $779,000
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $217,608 - $450,507	-58,813 Reduced 74.43%	20,200 $130,000
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $236,828 - $335,678	68,646 Added 662.16%	79,013 $284,000
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $110,459 - $177,667	-33,271 Reduced 76.24%	10,367 $48,000
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $92,512 - $296,738	43,638 New	43,638 $149,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.